WA
TMO icon

Walsh & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Walsh & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Hold
50
– – 0.02% 155
2026
Q1 		$24.6K Hold
50
– – 0.02% 149
2025
Q4 		$29K Buy
+50
New +$28.3K 0.03% 140

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Walsh & Associates's TMO Position: Q2 2026 in Review

Walsh & Associates held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 50 shares worth $25.1K. The position accounts for 0.02% of the portfolio, ranked #155.

Walsh & Associates first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $29K in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Walsh & Associates held 50 shares of Thermo Fisher Scientific worth $25.1K as of Q2 2026.
  • Walsh & Associates left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Walsh & Associates's portfolio in Q2 2026, its #155 holding.
  • Walsh & Associates first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Walsh & Associates's Thermo Fisher Scientific position peaked at $29K in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Walsh & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.